KER-050

A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Arms / Cohorts

Experimental:KER-050 Cohort 1

Accepting patients

Experimental:KER-050 Cohort 2

Accepting patients

Experimental:KER-050 Cohort 3

Accepting patients

Experimental:KER-050 Cohort 4

Accepting patients

Experimental:KER-050 Cohort 5

Accepting patients

Experimental:KER-050 Dose Confirmation Cohort

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.